or Try an Advanced Search...

    Technical Analysis for VINC - Vincera Pharma, Inc.

    Grade Last Price % Change Price Change
    F 0.83 1.57% 0.01
    VINC closed up 1.57 percent on Wednesday, May 8, 2024, on 16 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: May 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical VINC trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    NR7 Range Contraction 1.57%
    Narrow Range Bar Range Contraction 1.57%
    Down 3 Days in a Row Weakness 1.57%
    Narrow Range Bar Range Contraction -1.66%
    Wide Bands Range Expansion -1.66%
    Narrow Range Bar Range Contraction -5.37%
    Older End-of-Day Signals for VINC ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 14 hours ago
    Possible NR7 about 15 hours ago
    Possible Inside Day about 15 hours ago
    Down 3% about 19 hours ago
    Down 2 % about 19 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    VINC Chart by TradingView
    Basic chart:

    Profile

    Vincera Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincera Pharma, Inc. is based in Santa Clara, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Treatment Of Cancer Lymphoma Hematology Leukemia Myelodysplastic Syndrome Anatomical Pathology

    Is VINC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 26 Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Apr 26 Vincerx Pharma dips 16%, prices $16M stock
    Apr 26 Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
    Apr 25 Vincerx Pharma announces proposed underwritten public offering of common stock and warrants
    Apr 25 Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
    Apr 9 Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
    Apr 9 Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 9 Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
    Apr 9 Dow Dips 150 Points; Laser Photonics Shares Spike Higher
    Apr 9 Vincerx in selloff after early-stage data for cancer therapy
    See more VINC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.3722
    52 Week Low 0.61
    Average Volume 1,089,983
    200-Day Moving Average 1.71
    50-Day Moving Average 3.64
    20-Day Moving Average 0.89
    10-Day Moving Average 0.85
    Average True Range 0.33
    RSI (14) 32.89
    ADX 37.16
    +DI 16.37
    -DI 37.66
    Chandelier Exit (Long, 3 ATRs) 0.65
    Chandelier Exit (Short, 3 ATRs) 1.66
    Upper Bollinger Bands 1.01
    Lower Bollinger Band 0.76
    Percent B (%b) 0.28
    BandWidth 28.31
    MACD Line -0.72
    MACD Signal Line -0.85
    MACD Histogram 0.1351
    Fundamentals Value
    Market Cap 17.75 Million
    Num Shares 21.4 Million
    EPS -2.31
    Price-to-Earnings (P/E) Ratio -0.36
    Price-to-Sales 0.00
    Price-to-Book 1.83
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.91
    Resistance 3 (R3) 0.91 0.87 0.90
    Resistance 2 (R2) 0.87 0.85 0.88 0.89
    Resistance 1 (R1) 0.85 0.84 0.84 0.86 0.89
    Pivot Point 0.82 0.82 0.81 0.82 0.82
    Support 1 (S1) 0.80 0.80 0.78 0.80 0.77
    Support 2 (S2) 0.77 0.79 0.77 0.77
    Support 3 (S3) 0.74 0.77 0.76
    Support 4 (S4) 0.75